Optimmune

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Optimmune is an ophthalmic ointment with ciclosporin as the active ingredient for the treatment of pannus and chronic idiopathic keratoconjunctivitis sicca in dogs. It is a veterinary product produced by Intervet, which is part of Merck. Optimmune was invented by Dr. Renee Kaswan, a DVM and professor at The University of Georgia. Dr. Kaswan is also the inventor of Restasis, the pharmaceutical that is the human version of Optimmune.

Optimmune is one of a very few drugs developed for animals and then modified for use in human medicine.

Description[edit]

White petrolatum-based ointment for ophthalmic use, containing 0.2% w/w ciclosporin Ph Eur.

Activity[edit]

Ciclosporin is an immunosuppressant with lacrimomimetic and anti-inflammatory properties.

Contraindications[edit]

Mild irritation in first few days of treatment. Treatment should be discontinued and professional advice sought. Do not use if fungal infection of the eye is suspected.

Package quantitative[edit]

  • 3.5-Gram tubes

Legality[edit]

In Canada, available only from veterinary with prescription. As of October 2011, a tube cost $72.

References[edit]